Facebook
Twitter
The Inspector General of the Department for Health & Human Services (HHS) announced late last month that Federal officials at the Centers for Medicare and Medicaid Services (CMS) have ignored previous recommendations regarding pricing, thus resulting in a failure to make savings of $251 million. The HHS report states that Medicare expenditure for infusion drugs “could have been reduced by $251 million in an 18 month period” had its officials implemented the HHS’s new payment methodology.
If you’re one of the many seriously concerned about continuing government wastage, please Like & Share this post.
